K. Kärre, H. G. Ljunggren, G. Piontek, and R. Kiessling, Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy, Nature, vol.319, pp.675-678, 1986.

N. K. Björkström, H. Ljunggren, and J. Michaëlsson, Emerging insights into natural killer cells in human peripheral tissues, Nat. Rev. Immunol, vol.16, pp.310-320, 2016.

J. Hanna, D. Goldman-wohl, Y. Hamani, I. Avraham, C. Greenfield et al.,

, Decidual NK cells regulate key developmental processes at the human fetal-maternal interface, Nat. Med, vol.12, pp.1065-1074

J. P. Goodridge, B. , and K. Malmberg, Newtonian cell interactions shape natural killer cell education, Immunol. Rev, vol.267, pp.197-213, 2015.

V. Béziat, H. Hilton, P. J. Norman, and J. A. Traherne, Deciphering the killer-cell immunoglobulin-like receptor system at super-resolution for natural killer and T-cell biology, Immunology, vol.150, pp.248-264, 2017.

M. P. Martin, X. Gao, J. Lee, G. W. Nelson, R. Detels et al., Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS, Nat. Genet, vol.31, pp.429-434, 2002.

M. P. Martin, Y. Qi, X. Gao, E. Yamada, J. N. Martin et al., Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1, Nat. Genet, vol.39, pp.733-740, 2007.

S. I. Khakoo, C. L. Thio, M. P. Martin, C. R. Brooks, X. Gao et al., HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection, Science, vol.305, pp.872-874, 2004.

S. E. Hiby, J. J. Walker, K. M. O'shaughnessy, C. W. Redman, M. Carrington et al., Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success, J. Exp. Med, vol.200, pp.957-965, 2004.

S. E. Hiby, R. Apps, A. M. Sharkey, L. E. Farrell, L. Gardner et al., Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2, J. Clin. Invest, vol.121, pp.4102-4110, 2010.
DOI : 10.1172/jci45856

A. Nakimuli, O. Chazara, S. E. Hiby, L. Farrell, S. Tukwasibwe et al., A KIR B centromeric region present in Africans but not Europeans protects pregnant women from pre-eclampsia, Proc. Natl. Acad. Sci, vol.112, pp.845-850, 2015.

C. J. Forlenza, J. E. Boudreau, J. Zheng, J. B. Le-luduec, E. Chamberlain et al., KIR3DL1 allelic polymorphism and HLA-B epitopes modulate response to anti-GD2 monoclonal antibody in patients with neuroblastoma, J. Clin. Oncol, vol.34, pp.2443-2451, 2016.

S. K. Anderson, Probabilistic bidirectional promoter switches: noncoding RNA takes control, Mol. Ther. Nucleic Acids, vol.3, p.191, 2014.
DOI : 10.1038/mtna.2014.42

URL : https://doi.org/10.1038/mtna.2014.42

R. Bari, P. Rujkijyanont, E. Sullivan, G. Kang, V. Turner et al., Effect of donor KIR2DL1 allelic polymorphism on the outcome of pediatric allogeneic hematopoietic stem-cell transplantation, J. Clin. Oncol, vol.31, pp.3782-3790, 2013.

F. Babor, A. R. Manser, J. C. Fischer, N. Scherenschlich, J. Enczmann et al., KIR ligand C2 is associated with increased susceptibility to childhood ALL and confers an elevated risk for late relapse, Blood, vol.124, pp.2248-2251, 2014.

A. Dutta, N. Saikia, J. Phookan, M. N. Baruah, and S. Baruah, Association of killer cell immunoglobulin-like receptor gene 2DL1 and its HLA-C2 ligand with family history of cancer in oral squamous cell carcinoma, Immunogenetics, vol.66, pp.439-448, 2014.

S. E. Hiby, R. Apps, O. Chazara, L. E. Farrell, P. Magnus et al., Maternal KIR in combination with paternal HLA-C2 regulate human birth weight, J. Immunol, vol.192, pp.5069-5073, 2014.

J. Kieckbusch, L. M. Gaynor, A. Moffett, and F. Colucci, MHC-dependent inhibition of uterine NK cells impedes fetal growth and decidual vascular remodelling, Nat. Commun, vol.5, p.3359, 2014.

N. Nemat-gorgani, H. G. Hilton, B. M. Henn, M. Lin, C. R. Gignoux et al., Different selected mechanisms attenuated the inhibitory interaction of KIR2DL1 with C2 + HLA-C in two indigenous human populations in Southern Africa, J. Immunol, vol.200, pp.2640-2655, 2018.

H. G. Hilton, L. A. Guethlein, A. Goyos, N. Nemat-gorgani, D. A. Bushnell et al., Polymorphic HLA-C receptors balance the functional characteristics of KIR haplotypes, J. Immunol, vol.195, pp.3160-3170, 2015.

S. E. Dunphy, K. J. Guinan, C. N. Chorcora, J. Jayaraman, J. A. Traherne et al., 2DL1, 2DL2 and 2DL3 all contribute to KIR phenotype variability on human NK cells, Genes Immun, vol.16, pp.301-310, 2015.

C. Mcerlean, A. A. Gonzalez, R. Cunningham, A. Meenagh, T. Shovlin et al., Differential RNA expression of KIR alleles, Immunogenetics, vol.62, pp.431-440, 2010.

K. Schönberg, M. Sribar, J. Enczmann, J. C. Fischer, and M. Uhrberg, Analyses of HLA-C-specific KIR repertoires in donors with group A and B haplotypes suggest a ligand-instructed model of NK cell receptor acquisition, Blood, vol.117, pp.98-107, 2011.

H. G. Hilton, P. J. Norman, N. Nemat-gorgani, A. Goyos, J. A. Hollenbach et al., Loss and gain of natural killer cell receptor function in an African Hunter-Gatherer population, PLoS Genet, vol.11, p.1005439, 2015.

R. Bari, T. Bell, W. H. Leung, Q. P. Vong, W. K. Chan et al., Significant functional heterogeneity among KIR2DL1 alleles and a pivotal role of arginine 245, Blood, vol.114, pp.5182-5190, 2009.

M. Yawata, N. Yawata, M. Draghi, F. Partheniou, A. M. Little et al., MHC class I-specific inhibitory receptors and their ligands structure diverse human NK-cell repertoires toward a balance of missing self-response, Blood, vol.112, pp.2369-2380, 2008.

V. Béziat, J. A. Traherne, L. L. Liu, J. Jayaraman, M. Enqvist et al., Influence of KIR gene copy number on natural killer cell education, Blood, vol.121, pp.4703-4707, 2013.

M. Falco, E. Romeo, S. Marcenaro, S. Martini, M. Vitale et al., Combined genotypic and phenotypic killer cell Ig-like receptor analyses reveal KIR2DL3 alleles displaying unexpected monoclonal antibody reactivity: identification of the amino acid residues critical for staining, J. Immunol, vol.185, pp.433-441, 2010.

S. E. Hiby, L. Regan, W. Lo, L. Farrell, M. Carrington et al., Association of maternal killer-cell immunoglobulin-like receptors and parental HLA-C genotypes with recurrent miscarriage, Hum. Reprod, vol.23, pp.972-976, 2008.

W. Jiang, C. Johnson, J. Jayaraman, N. Simecek, J. Noble et al., Copy number variation leads to considerable diversity for B but not A haplotypes of the human KIR genes encoding NK cell receptors, Genome Res, vol.22, pp.1845-1854, 2012.

P. J. Norman, J. A. Hollenbach, N. Nemat-gorgani, L. A. Guethlein, H. G. Hilton et al., Co-evolution of human leukocyte antigen (HLA) class I ligands with killer-cell immunoglobulin-like receptors (KIR) in a genetically diverse population of sub-Saharan Africans, PLoS Genet, vol.9, p.1003938, 2013.

V. Male, L. Gardner, and A. Moffett, Isolation of cells from the fetomaternal interface, Curr. Protoc. Immunol. Chapter, 2012.

C. Fauriat, M. A. Ivarsson, H. Ljunggren, K. Malmberg, and J. Michaëlsson, Education of human natural killer cells by activating killer cell immunoglobulin-like receptors, Blood, vol.115, pp.1166-1174, 2010.

Y. T. Bryceson, C. Fauriat, J. M. Nunes, S. M. Wood, N. K. Björkström et al., Functional analysis of human NK cells by flow cytometry, Methods Mol. Biol, vol.612, pp.335-352, 2010.

G. David, M. Morvan, K. Gagne, N. Kerdudou, C. Willem et al., Discrimination between the main activating and inhibitory killer cell immunoglobulin-like receptor positive natural killer cell subsets using newly characterized monoclonal antibodies, Immunology, vol.128, pp.172-184, 2009.

A. King, N. Balendran, P. Wooding, N. P. Carter, and Y. W. Loke, CD3leukocytes present in the human uterus during early placentation: phenotypic and morphologic characterization of the CD56++ population, Dev. Immunol, vol.1, pp.169-190, 1991.

V. Male, A. Sharkey, L. Masters, P. R. Kennedy, L. E. Farrell et al., The effect of pregnancy on the uterine NK cell KIR repertoire, Eur. J. Immunol, vol.41, pp.3017-3027, 2011.

M. A. Ivarsson, N. Stiglund, N. Marquardt, M. Westgren, S. Gidlöf et al., Composition and dynamics of the uterine NK cell KIR repertoire in menstrual blood, Mucosal Immunol, vol.10, pp.322-331, 2017.

S. Xiong, A. M. Sharkey, P. R. Kennedy, L. Gardner, L. E. Farrell et al., Maternal uterine NK cellactivating receptor KIR2DS1 enhances placentation, J. Clin. Invest, vol.123, pp.4264-4272, 2013.

A. M. Sharkey, S. Xiong, P. R. Kennedy, L. Gardner, L. E. Farrell et al., Tissue-specific education of decidual NK cells, J. Immunol, vol.195, pp.3026-3032, 2015.

C. M. Gardiner, L. A. Guethlein, H. G. Shilling, M. Pando, W. H. Carr et al., Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism, J. Immunol, vol.166, pp.2992-3001, 2001.

H. Li, V. Pascal, M. P. Martin, M. Carrington, and S. K. Anderson, Genetic control of variegated KIR gene expression: polymorphisms of the bidirectional KIR3DL1 promoter are associated with distinct frequencies of gene expression, PLoS Genet, vol.4, p.1000254, 2008.

V. Béziat, L. L. Liu, J. Malmberg, M. A. Ivarsson, E. Sohlberg et al., NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs, Blood, vol.121, pp.2678-2688, 2013.

V. Béziat, O. Dalgard, T. Asselah, P. Halfon, P. Bedossa et al., CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients, Eur. J. Immunol, vol.42, pp.447-457, 2012.

A. Moffett and F. Colucci, Uterine NK cells: active regulators at the maternal-fetal interface, J. Clin. Invest, vol.124, pp.1872-1879, 2014.

R. S. Ahn, H. Moslehi, M. P. Martin, M. Abad-santos, A. M. Bowcock et al., Inhibitory KIR3DL1 alleles are associated with psoriasis, Br. J. Dermatol, vol.174, pp.449-451, 2016.

D. G. Augusto, G. M. O'connor, S. C. Lobo-alves, S. Bass, M. P. Martin et al., Pemphigus is associated with KIR3DL2 expression levels and provides evidence that KIR3DL2 may bind HLA-A3 and A11 in vivo, Eur. J. Immunol, vol.45, pp.2052-2060, 2015.

R. Bari, R. Thapa, J. Bao, Y. Li, J. Zheng et al., KIR2DL2/ 2DL3-E(35) alleles are functionally stronger than-Q(35) alleles, Sci. Rep, vol.6, p.23689, 2016.